Mylan (Nasdaq: MYL), which is run from its corporate offices at Southpointe, said it will start selling remdesivir 100 mg/vial under the brand name Desrem in India in July. Remdesivir is an antiviral medication developed by Gilead Sciences Inc. that has shown promise in treating severe Covid-19 cases. Mylan and Gilead (Nasdaq: GIL) have a deal to commercialize remdesivir in 127 countries around the world and the companies have worked to tackle public health problems before, including HIV.
Read Again https://www.wpxi.com/news/business/mylan-manufacture-covid-19-treatment-india/CDTHZJQOVBBNZMRZVIRPI3VRBI/Bagikan Berita Ini
0 Response to "Mylan to manufacture Covid-19 treatment for India - WPXI Pittsburgh"
Post a Comment